Latest News
Featured News
Scancell to present positive Phase 2 data on Immunobody® iSCIB1+ in late-stage melanoma at SITC 2025
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Select the category
Scancell to present at the Next-Gen Immuno-Oncology Conference
Scancell Change of Auditor
Directorate Change and Appointment of Head of Development
Interim Results for the six months ended 31 October 2023
Notice of Interim Results and Presentation
MHRA approval to add a third cohort using iSCIB1+ to the SCOPE trial
No results found.
Regulatory News Archive
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.